natriuretic

(redirected from Natriuretic peptides)
Also found in: Dictionary, Encyclopedia.

natriuretic

 [na″tre-u-ret´ik]
1. pertaining to natriuresis.
2. promoting natriuresis.
3. an agent that so acts.

na·tri·u·ret·ic

(nā'trē-yū-ret'ik),
1. Pertaining to or characterized by natriuresis.
2. A substance that increases urinary excretion of sodium, usually as a result of decreased tubular reabsorption of sodium ions from glomerular filtrate.

natriuretic

adjective Referring to sodium excretion (by the kidneys).
 
noun An agent (e.g., atrial natriuretic hormone) that promotes urinary excretion of sodium.

na·tri·u·ret·ic

(nā'trē-yū-ret'ik)
1. Pertaining to or characterized by natriuresis.
2. A substance that increases urinary excretion of sodium, usually as a result of decreased tubular reabsorption of sodium ions from glomerular filtrate.
References in periodicals archive ?
B-type brain natriuretic peptide exists in brain tissue and myocardial tissue, and has a sensitive prediction function for the degree of heart failure.
The architect BNP assay is a chemiluminescent microparticle immunoassay (CMIA) used for the quantitative determination of human brain natriuretic peptide in human ethylenediaminetetraacetic acid (EDTA) plasma on ARCHITECT I system.
Across all VLBW cases and control subjects combined, of the many conventional risk factors examined, natriuretic peptides were significantly associated with 7 (Table 3).
Made in the heart, atrial and B-type natriuretic peptides (NPs) are hormones that were originally discovered to modulate salt and water to control blood pressure.
Horl, "Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy," Journal of Investigative Medicine, vol.
B-type natriuretic peptide (BNP) is produced by the stressed heart, namely, the stressed ventricles, and is a mostly friendly counter-regulatory peptide [8].
Therefore, the currently available data suggests that the performance characteristics and utility of natriuretic peptides for determination of congestion and volume status in the dialysis population are not similar to patient with HF and fluid overload.
B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies.
The administration of synthesized analogous of natriuretic peptides (as nesiritide and anaritide) or inhibitors of the catabolic enzyme 24.11 endopeptidase (candoxatril, omapatrilat, neprilysin, and ecadotril) may be a useful tool to regulate the expression of key components of tubulointerstitial inflammation in the kidney and to control the oxygen supply or demand, under circumstances of sodium overload.
Several studies that used natriuretic peptides in predischarge indicate that BNP levels appear to be the strongest predictor for identifying subsequent death or hospital admission within 6 months [25, 29].